Global therapeutic medicinal cannabis company, Zelira Therapeutics
(ASX:ZLD) has expanded into the dental health market by launching a scientifically formulated, hemp-derived cannabinoid-based oral care products subsidiary.
The company has joined forces with USDA Bio-preferred natural toothpaste developer SprinJene and Health and Natural Beauty USA Corp in this USA-based venture. The company aims to release to the US market a cannabinoid-containing toothpaste, its first over-the-counter product in the USA by Q4 2020.
In addition, Zelira Therapeutics
(ASX:ZLD) remains confident that it is on track to deliver four more new products in global markets this year.
Shares in Zelira Therapeutics
(ASX:ZLD) are trading 3.45 per cent higher at 6 cents
